For patients with mitral valve disease who have limited other options and for whom surgery is a very high risk, the experts at WVU Heart and Vascular Institute’s Center for Mitral Valve Disease are ready to help.

Backed by our team of cardiologists, surgeons, nurses, and anesthesiologists, the WVU Heart and Vascular Institute is the first in West Virginia to perform a minimally invasive procedure to implant the Tendyne Bioprosthetic Mitral Valve to combat mitral regurgitation. The institute is one of only 25 institutions worldwide chosen to participate in the clinical trial of this device.

View more videos >>

Clinical Trials

WVU Medicine © 2017